Table of Contents_x000D_
List of Tables_x000D_
List of Figures_x000D_
1 Introduction_x000D_
1.1 What Is This Report About?_x000D_
1.2 Hormonal Disorders Market Segmentation_x000D_
1.3 Definitions of Markets Covered in the Report_x000D_
2 Hormonal Disorders Market, EU5_x000D_
2.1 Hormonal Disorders Market, EU5, Revenue ($m), 2024-2036_x000D_
2.2 Hormonal Disorders Market, EU5, Revenue ($m), 2024-2036_x000D_
2.3 Hormonal Disorders Market, EU5, Volume (Units), 2024-2036_x000D_
2.4 Hormonal Disorders Market, EU5, Volume (Units), 2024-2036_x000D_
2.5 Hormonal Disorders Market, EU5, Company Share by Revenue ($m), 2025_x000D_
3 Hormonal Disorders Market, France_x000D_
3.1 Hormonal Disorders Market, France, Revenue ($m), 2024-2036_x000D_
3.1.1 Thyroid Function Tests Market, France, Revenue ($m), by Segment, 2024-2036_x000D_
3.2 Hormonal Disorders Market, France, Volume (Units), 2024-2036_x000D_
3.2.1 Thyroid Function Tests Market, France, Volume (Units), by Segment, 2024-2036_x000D_
3.3 Hormonal Disorders Market, France, Average Price ($), 2024-2036_x000D_
3.4 Hormonal Disorders Market, France, Company Share by Revenue ($m), 2025_x000D_
4 Hormonal Disorders Market, Germany_x000D_
4.1 Hormonal Disorders Market, Germany, Revenue ($m), 2024-2036_x000D_
4.1.1 Thyroid Function Tests Market, Germany, Revenue ($m), by Segment, 2024-2036_x000D_
4.2 Hormonal Disorders Market, Germany, Volume (Units), 2024-2036_x000D_
4.2.1 Thyroid Function Tests Market, Germany, Volume (Units), by Segment, 2024-2036_x000D_
4.3 Hormonal Disorders Market, Germany, Average Price ($), 2024-2036_x000D_
4.4 Hormonal Disorders Market, Germany, Company Share by Revenue ($m), 2025_x000D_
5 Hormonal Disorders Market, Italy_x000D_
5.1 Hormonal Disorders Market, Italy, Revenue ($m), 2024-2036_x000D_
5.1.1 Thyroid Function Tests Market, Italy, Revenue ($m), by Segment, 2024-2036_x000D_
5.2 Hormonal Disorders Market, Italy, Volume (Units), 2024-2036_x000D_
5.2.1 Thyroid Function Tests Market, Italy, Volume (Units), by Segment, 2024-2036_x000D_
5.3 Hormonal Disorders Market, Italy, Average Price ($), 2024-2036_x000D_
5.4 Hormonal Disorders Market, Italy, Company Share by Revenue ($m), 2025_x000D_
6 Hormonal Disorders Market, Spain_x000D_
6.1 Hormonal Disorders Market, Spain, Revenue ($m), 2024-2036_x000D_
6.1.1 Thyroid Function Tests Market, Spain, Revenue ($m), by Segment, 2024-2036_x000D_
6.2 Hormonal Disorders Market, Spain, Volume (Units), 2024-2036_x000D_
6.2.1 Thyroid Function Tests Market, Spain, Volume (Units), by Segment, 2024-2036_x000D_
6.3 Hormonal Disorders Market, Spain, Average Price ($), 2024-2036_x000D_
6.4 Hormonal Disorders Market, Spain, Company Share by Revenue ($m), 2025_x000D_
7 Hormonal Disorders Market, United Kingdom_x000D_
7.1 Hormonal Disorders Market, United Kingdom, Revenue ($m), 2024-2036_x000D_
7.1.1 Thyroid Function Tests Market, United Kingdom, Revenue ($m), by Segment, 2024-2036_x000D_
7.2 Hormonal Disorders Market, United Kingdom, Volume (Units), 2024-2036_x000D_
7.2.1 Thyroid Function Tests Market, United Kingdom, Volume (Units), by Segment, 2024-2036_x000D_
7.3 Hormonal Disorders Market, United Kingdom, Average Price ($), 2024-2036_x000D_
7.4 Hormonal Disorders Market, United Kingdom, Company Share by Revenue ($m), 2025_x000D_
8 Hormonal Disorders Market Pipeline Products_x000D_
8.1 Hormonal Disorders Market Pipeline Products_x000D_
8.2 Hormonal Disorders – Pipeline Products by Stage of Development_x000D_
8.3 Hormonal Disorders – Pipeline Products by Segment_x000D_
8.4 Hormonal Disorders – Pipeline Products by Territory_x000D_
8.5 Hormonal Disorders – Pipeline Products by Regulatory Path_x000D_
8.6 Hormonal Disorders – Pipeline Products by Estimated Approval Date_x000D_
9 Overview of Key Companies in EU5 Hormonal Disorders Market_x000D_
9.1 Siemens Healthineers AG_x000D_
9.1.1 Company Overview_x000D_
9.2 Abbott Laboratories_x000D_
9.2.1 Company Overview_x000D_
9.3 Roche Diagnostics International Ltd_x000D_
9.3.1 Company Overview_x000D_
9.4 Beckman Coulter Inc_x000D_
9.4.1 Company Overview_x000D_
9.5 Ortho Clinical Diagnostics Holdings Ltd (Inactive)_x000D_
9.5.1 Company Overview_x000D_
10 Recent Developments_x000D_
10.1 Corporate Communications_x000D_
10.1.1 Nov 05, 2025: Waardenburg Syndrome and Piebaldism_x000D_
10.1.2 Nov 03, 2025: Androstenedione Elisa – New Release_x000D_
10.1.3 Oct 28, 2025: Tanenbaum Institute for Science in Sport and Saint-Étienne University Hospital Collaborate on Sport and Health Research_x000D_
10.1.4 Oct 21, 2025: Novo Nordisk Foundation Proposes New Board Members for Novo Nordisk A/S_x000D_
10.1.5 Oct 16, 2025: Reflections On Diagnostics At IPSC 2025_x000D_
10.1.6 Oct 13, 2025: EASL CPGs Dissemination And Implementation Programme_x000D_
10.2 Financial Announcements_x000D_
10.2.1 Feb 05, 2026: Siemens Healthineers Announces Q1 Results for Fiscal Year 2026_x000D_
10.2.2 Nov 13, 2025: Integrated Diagnostics Holdings Delivers 41% Revenue Growth in 9M 2025 With Continued Margin Expansion and Robust Bottom-Line Performance_x000D_
10.3 Government and Public Interest_x000D_
10.3.1 Jan 12, 2026: Eckert & Ziegler to Attend J.P. Morgan Healthcare Conference_x000D_
10.4 Other Significant Developments_x000D_
10.4.1 Nov 05, 2025: Skolkovo Launches Grant Support for Technological Leaders_x000D_
10.4.2 Oct 28, 2025: Tanenbaum Institute for Science in Sport and Saint-Étienne University Hospital Collaborate on Sport and Health Research_x000D_
10.5 Product News_x000D_
10.5.1 Feb 17, 2026: BioMed X Launches XFem Labs Women's Health Accelerator With Pitch Event_x000D_
10.5.2 Nov 17, 2025: ScreenCell Standardizes CTC Isolation Kits to Two Filtration Units_x000D_
10.5.3 Nov 14, 2025: Scientists Invent New Method for Producing Platelet-Producing Cells from Stem Cells_x000D_
10.5.4 Nov 11, 2025: Samsung Active Asset Management Launches KoAct US Biohealthcare Active ETF Benchmarking the Solactive US Biohealthcare Index_x000D_
10.5.5 Oct 30, 2025: FNCC RR Showcases Innovative Developments at All-Russian Exhibition_x000D_
10.5.6 Sep 19, 2025: University of Turku Launches ICDx Project for Commercialization of Next-Generation Hormone Tests_x000D_
10.6 Research And Development_x000D_
10.6.1 Nov 05, 2025: Skolkovo Launches Grant Support for Technological Leaders_x000D_
10.7 Strategy And Business Planning_x000D_
10.7.1 Nov 11, 2025: Samsung Active Asset Management Launches KoAct US Biohealthcare Active ETF Benchmarking the Solactive US Biohealthcare Index_x000D_
10.7.2 Oct 28, 2025: Tanenbaum Institute for Science in Sport and Saint-Étienne University Hospital Collaborate on Sport and Health Research_x000D_
10.7.3 Oct 22, 2025: HMI Medical Expands Imaging Services in Singapore_x000D_
11 Appendix_x000D_
11.1 Research Methodology_x000D_
11.1.1 Coverage_x000D_
11.1.2 Secondary Research_x000D_
11.1.3 Primary Research_x000D_
11.1.4 Market Modeling and Forecasting_x000D_
11.1.5 Company Share Analysis_x000D_
11.1.6 Benchmarking_x000D_
11.2 GlobalData Consulting_x000D_
11.3 Contact Us_x000D_
11.4 Disclaimer